Back

Informing patients about potential adverse drug reactions after percutaneous coronary intervention reduces the occurrence of self-reported adverse drug reactions

28 August 2022 (13:15 - 13:30)
Organised by:
Congress Presentation Part of: Nursing and Allied Professions Investigator Awards Chronic Nursing Care ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Trond Roed Pettersen

Haukeland University Hospital, Bergen (Norway)

3 More presentations in this session

Presentation thumbnail
Clinical impact of improving sarcopenia through cardiac rehabilitation in patients with heart failure
Ms S. Shakuta (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
End-of-life and palliative care provision to adults with congenital heart disease: mortality follow-back study using administrative data
Miss L. Van Bulck (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Sustained effect on diet quality of a self-care intervention to reduce cardiovascular disease risk among informal rural caregivers of people with chronic illnesses: does health literacy matter?
Doctor J. Kang (Lexington, US)
Abstract Slides Video

Access the full session

Session thumbnail
Nursing and Allied Professions Investigator Awards

The Event

Event poster

ESC Congress 2022

28 August 2022 13:15 CET
You may be interested in
thumbnail
Congress Session
Beyond stenting: optimising adjunctive pharmacotherapy for myocardial infarction
thumbnail
Congress Session
Nursing and Allied Professions Investigator Awards
thumbnail
Congress Session
Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources